Literature DB >> 9924382

Brain natriuretic peptide: identification of a second natriuretic peptide in human aqueous humour.

J Salzmann1, D Flitcroft, C Bunce, D Gordon, R Wormald, C Migdal.   

Abstract

AIMS/
BACKGROUND: To measure aqueous humour levels of brain natriuretic peptide (BNP) and atrial natriuretic peptide (ANP) in humans. To compare peptide levels in glaucomatous and control eyes to test the hypothesis that these peptides are increased in glaucoma. BNP and ANP are cyclic endopeptides whose principal biological effects are natriuresis and vasodilatation. Experimental glaucoma in animal models results in elevated aqueous ANP. Intravenous ANP administration in both animals and humans causes lowering of intraocular pressure (IOP). There are equivocal data to support a role for ANP in IOP regulation in human eyes. There are as yet no published data on BNP in human aqueous humour.
METHOD: This was a case-control study. Cases were primary open angle, pseudoexfoliation, and mixed mechanism glaucoma eyes undergoing trabeculectomy. Controls were cataract extraction eyes. There were 47 trabeculectomy eyes (44 patients) and 47 cataract extraction eyes (46 patients) matched for age, sex, race, systemic medications, and type of anaesthetic. 100-200 microliters of aqueous humour were aspirated by paracentesis as the first step in the surgical procedure. Peptide levels were later measured by radioimmunoassay.
RESULTS: The presence of BNP and ANP in human aqueous humour was confirmed. BNP was present in higher concentrations than ANP. BNP levels tended to be greater in control eyes--glaucoma median 56.5 (range 0-3526.5) pg/ml versus control median 65.16 (range 0-1788) pg/ml (Wilcoxon signed rank test p = 0.78). ANP levels tended to be greater in glaucoma eyes than in controls: glaucoma median 3 (range 0-68.5) pg/ml versus control median 0 (range 0-60) pg/ml (Wilcoxon signed rank test p = 0.82). ANP and BNP were log linearly related in both groups (r glaucoma group = 0.961, r control group = 0.894).
CONCLUSION: This is the first report of BNP and ANP in human aqueous humour. Peptide levels did not differ significantly between glaucoma and cataract extraction eyes. A linear relation between log BNP and ANP was found. Further studies are required to clarify the role of these peptides in aqueous humour production and IOP regulation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9924382      PMCID: PMC1722682          DOI: 10.1136/bjo.82.7.830

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  23 in total

1.  Effect of combined peribulbar and retrobulbar injection of large volumes of anesthetic agents on the intraocular pressure.

Authors:  D Meyer; R C Hamilton; R G Loken; H V Gimbel
Journal:  Can J Ophthalmol       Date:  1992-08       Impact factor: 1.882

2.  Atrial natriuretic peptides. Effects on intraocular pressure, cGMP, and aqueous flow.

Authors:  M S Korenfeld; B Becker
Journal:  Invest Ophthalmol Vis Sci       Date:  1989-11       Impact factor: 4.799

3.  Immunoactive atrial natriuretic peptide in the rat eye: molecular forms in anterior uvea and retina.

Authors:  R A Stone; C C Glembotski
Journal:  Biochem Biophys Res Commun       Date:  1986-01-29       Impact factor: 3.575

4.  Immunoreactive atrial natriuretic factor in aqueous humor: its concentration is increased with high intraocular pressure in rabbit eyes.

Authors:  R Fernandez-Durango; A Triviño; J M Ramirez; M Garcia de Lacoba; A Ramirez; J J Salazar; A Fernandez-Cruz; J Gutkowska
Journal:  Vision Res       Date:  1990       Impact factor: 1.886

5.  Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.

Authors:  M Mukoyama; K Nakao; K Hosoda; S Suga; Y Saito; Y Ogawa; G Shirakami; M Jougasaki; K Obata; H Yasue
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

6.  Atriopeptin-activated guanylate cyclase in the anterior segment. Identification, localization, and effects of atriopeptins on IOP.

Authors:  J A Nathanson
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-08       Impact factor: 4.799

7.  Characterization of immunoreactive brain natriuretic peptide in human cardiac atrium.

Authors:  H Tateyama; J Hino; N Minamino; K Kangawa; T Ogihara; H Matsuo
Journal:  Biochem Biophys Res Commun       Date:  1990-02-14       Impact factor: 3.575

8.  Acute sternal opening after cardiac surgery in children: effect on plasma atrial natriuretic peptide.

Authors:  M Burch; C Lincoln; N Carter; A Smith
Journal:  J Cardiovasc Surg (Torino)       Date:  1991 Mar-Apr       Impact factor: 1.888

9.  The intraocular pressure response of human atrial natriuretic factor in glaucoma.

Authors:  M Diestelhorst; G K Krieglstein
Journal:  Int Ophthalmol       Date:  1989-01       Impact factor: 2.031

10.  Effects of atrial natriuretic factor (ANF) on intraocular pressure and aqueous humor flow in the cynomolgus monkey.

Authors:  M Samuelsson-Almén; S F Nilsson; O Mäepea; A Bill
Journal:  Exp Eye Res       Date:  1991-08       Impact factor: 3.467

View more
  4 in total

1.  Evidence-based pathophysiology of glaucoma.

Authors:  Cristina Alexandrescu; Ana-Maria Dascalu; Costin Mitulescu; Aida Panca; Ruxandra Pascu; Radu Ciuluvica; V Potop; Liliana Mary Voinea
Journal:  Maedica (Buchar)       Date:  2010-07

2.  Evaluation of postmortem measurement of NT-proBNP as a marker for cardiac function.

Authors:  Katarzyna Michaud; Marc Augsburger; Nicolas Donzé; Sara Sabatasso; Mohamed Faouzi; Marc Bollmann; Patrice Mangin
Journal:  Int J Legal Med       Date:  2008-06-14       Impact factor: 2.686

Review 3.  Circulating biomarkers in glaucoma, age-related macular degeneration, and diabetic retinopathy.

Authors:  Madhu Nath; Nabanita Halder; Thirumurthy Velpandian
Journal:  Indian J Ophthalmol       Date:  2017-03       Impact factor: 1.848

4.  A Good Way to Reduce Screening for Retinopathy of Prematurity: Development of the ROP Model in a China Preterm Population.

Authors:  Wenqian Ding; Chenghan Luo; Xinru Cheng; Zanyang Shi; Mengyuan Lei; Junbo Rong; Min Song; Wenjun Cao; Jingdi Zhang; Jian Ge; Mengmeng Wang; Yixia Zhang; Peige Xia; Li Wang; Yufeng Liu; Qian Zhang
Journal:  Front Pediatr       Date:  2021-06-30       Impact factor: 3.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.